GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CKD Bio Corp (XKRX:063160) » Definitions » Long-Term Capital Lease Obligation

CKD Bio (XKRX:063160) Long-Term Capital Lease Obligation : ₩879 Mil (As of Mar. 2024)


View and export this data going back to 2001. Start your Free Trial

What is CKD Bio Long-Term Capital Lease Obligation?

CKD Bio's Long-Term Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₩879 Mil.

CKD Bio's quarterly Long-Term Capital Lease Obligation declined from Sep. 2023 (₩1,146 Mil) to Dec. 2023 (₩992 Mil) and declined from Dec. 2023 (₩992 Mil) to Mar. 2024 (₩879 Mil).

CKD Bio's annual Long-Term Capital Lease Obligation increased from Dec. 2021 (₩79 Mil) to Dec. 2022 (₩1,537 Mil) but then declined from Dec. 2022 (₩1,537 Mil) to Dec. 2023 (₩992 Mil).


CKD Bio Long-Term Capital Lease Obligation Historical Data

The historical data trend for CKD Bio's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CKD Bio Long-Term Capital Lease Obligation Chart

CKD Bio Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Long-Term Capital Lease Obligation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,239.34 681.69 79.20 1,536.82 992.24

CKD Bio Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Long-Term Capital Lease Obligation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,467.96 1,330.24 1,145.99 992.24 879.05

CKD Bio  (XKRX:063160) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

CKD Bio Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of CKD Bio's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.


CKD Bio (XKRX:063160) Business Description

Industry
Traded in Other Exchanges
N/A
Address
368 Chungjeongno 3-ga, Seodaemun-gu, Seoul, KOR, 120-756
CKD Bio Corp is engaged in manufacturing and distribution of pharmaceutical materials and medicines. Its products portfolio include antibiotic, lactamase inhibitors, antituberculosis, antidiabetics, immunosuppressants, antihyperlipidemics, intermediates, and probiotics.

CKD Bio (XKRX:063160) Headlines

No Headlines